CDC recommends Pfizer's RSV vaccine during pregnancy as protection for newborns
CBSN
An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory syncytial virus, or RSV, be given during pregnancy, providing an extra level of protection for newborns against the disease.
The panel recommended in an 11-1 vote that Pfizer's Abrysvo be given during weeks 32 to 36 of pregnancy. The recommendation was formally adopted by CDC Director Dr. Mandy Cohen.
Abrysvo was approved by the Food and Drug Administration for administration to pregnant people last month but needed the CDC's approval as well before it could be added to a list of "maternal vaccines" recommended before birth.
A class of drugs known as GLP-1s have been helping people lose weight, but out of pocket costs put them out of reach for many Americans. In West Virginia, a subsidy program for public employees was showing promising results, but then the state abruptly ended it, leaving many searching for new solutions.